E-Folder
#1 in Business Subscribe Email Print

You are here: Home > Business > Strategic Planning > Strategic Planning – The 2 Gaping Pitfalls

Tags

  • large
  • accurate
  • challenges
  • strategic planning
  • combination products
  • companies involved

  • Links

  • A Scathing Article on the Current Administration
  • Anniversary Gifts - The List
  • NCAA Tournament Report - Final Four
  • E-Folder - Strategic Planning – The 2 Gaping Pitfalls

    80% of successful businesses have strategic plans for their organization. Even then, Strategic Plans can be less effective, even become superfluous due to two significant errors that even large corporations may make. The fir
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    st is YOU, whether you are the owner, CEO or the Executive Team. The second is doing Check Ups on the plan after it’s implementation.

    The absence of YOU in the process

    It doesn’t matter whether this is for a one person comp
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ny or for a large corporation. It doesn’t matter which Strategic Planning model that you use for your organization. YOU must be involved in ALL three stages of the Strategic Planning process.

    The 3 stages are –
    1. Knowl
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    edge gathering. This is where you determine what the vision of the organization is, in other words where you want it to go. You also look at your resources and the marketplace.
    2. The actual Strategic Planning process.
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    his is where you determine HOW you’re going to get where you want to go, creating your own roadmap. During the process, it will be determined what resources you may need, etc. to achieve your goals.
    3. Carrying out the
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    trategic Plan. OK. Now you have the plan in your hands. It’s time to launch.

    Most organizations don’t wish to be bothered with the 2nd stage. They hire consultants to come in, interview (stage 1), disappear and then ta-da, y
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    our consultant returns with a 400 page strategic plan that THEY created that YOU need to carry out to get the results you said you wanted. Let’s face it; you’re not going to read that 400 page report, so they may give you a 2
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    page summary and a mind numbing PowerPoint presentation for you and your team.

    So is this plan accurate?
    Is this plan what you want to do?
    Does this plan accurately reflect optimal use of your resources?
    Do
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    you fully agree with the plan and what you’re expected to do?
    Are you going to effectively carry out this plan?

    The answer to all of these questions is…maybe, maybe not.

    So what happened?

    Stage 1, the knowledge gathe
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ing stage, you’re involved. And then when it comes time to take that knowledge and use it to make the most effective path forward for your organization, what happened? You’re not there.

    So put YOU in stage 2, the actual proc
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ss. It may be you alone. It may be a team. But when done correctly, by putting YOU in stage 2, you develop a strategic plan that is not only for more accurate in it’s detail, but since YOU created it, when it comes time for s
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    tage 3, carrying out the plan, YOU and your team have bought into where you want to go and exactly what you need to do to get there. If in a team environment, going through the process allows the team to build stronger apprec
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ation for each other’s strengths and contributions, providing improved results throughout the organization.

    CHECK UPS FOR YOUR PLAN

    The second gaping pitfall for any Strategic Plan is after it’s been launched. The cheering
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    crowds have moved in, the band has been paid off, the balloons and streamers have been cleaned up. Chances are you’ll start out right on target.

    But think of a road trip. You need to keep your hand on the steering wheel othe
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    wise the car will veer off the road. Same with the strategic plan. What happens when you hit a road block and now you have to turn in a different direction? You need to figure out how to get back on course!

    This is what happ
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ns with the best laid strategic plan. Stuff happens. Markets change. You lose a prime contributor. There are a million things that can occur that change the course of your plan. So you have two options.

    The first is to throw
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    the plan away and give up. Proof that it doesn’t work.

    The second option is to periodically do a check up on the plan. Look at your measurable goals that you have and determine where you are now. If you aren’t where you pla
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ned on being, why not? And then look at what you need to do to get back on track, just like that road trip detour, remap what you need to do to get back on plan. By periodically checking on how your plan is doing, you can s
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    tay on your path to reach the vision of where you want your organization to be and you can make those corrections long before they become too big to resolve and sabotage your plan.

    Thinking strategically, by being fully invo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ved in the strategic planning process and by periodically checking up on the plan’s progress, you greatly enhance the prospect of your organization successfully achieving the vision that you desired when you began the process


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-folder.org.ua/article/44257/e-folder-Strategic-Planning--The-2-Gaping-Pitfalls.html">Strategic Planning – The 2 Gaping Pitfalls</a>

    BB link (for phorums):
    [url=http://www.e-folder.org.ua/article/44257/e-folder-Strategic-Planning--The-2-Gaping-Pitfalls.html]Strategic Planning – The 2 Gaping Pitfalls[/url]

    Related Articles:

    Stock Broker Career

    Is The Fear of Failure Holding You Back?

    Planning Is Taking Advantage Of Risks

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com